Honeynaps Co., Ltd.

Honeynaps Co., Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on June 27, 2026 and the most recent on June 27, 2026 (SOMNUM (SOMNUM)). Its most common review panel is Neurology (1 device).